Rare Disease Patient Community Letter to FDA Commissioner Makary June 24, 2025 Share this page 101 patient advocacy organizations request the establishment of a complementary town hall-style meeting series to strengthen engagement between the FDA and patient advocacy groups. Patient-Focused Drug Development (PFDD) Related Articles Breaking News: The FDA has released the draft goals letter for PDUFA VIII August 13, 2026 The EveryLife Foundation Submits Comments to Support Patient-Focused Drug Development and Medical Innovation July 01, 2026 FDA Rare Disease Roundtable – June 3, 2026 June 04, 2026 See All News